Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population
Jianxin Shi(National Cancer Institute), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Qiuyin Cai(Vanderbilt University), Jiang Chang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Jie Seow(National University Health System), Shilan Li(Leidos (United States)), Bryan A. Bassig(Inova Health System), Jiyeon Choi(Korea University), Li-Hsin Chien(National Health Research Institutes), Lei Song(Nantong University), Baosen Zhou(First Hospital of China Medical University), Neil E. Caporaso(Unknown), Shejuan An(Northwestern University), Kouya Shiraishi, Zhihua Yin(China Medical University), Batel Blechter(National Institutes of Health), Demetrius Albanes(National Cancer Institute), Jcm Ho(Queen Mary Hospital), Juncheng Dai(Nanjing Medical University), Tzu-Yu Chen(National Health Research Institutes), Hong Zheng, Jiucun Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Karen Funderburk(National Institutes of Health), Rayjean J. Hung, Tongwu Zhang(National Cancer Institute), Jason Y.Y. Wong(National Institutes of Health), Yasushi Yatabe(University Hospital Münster), Keitaro Matsuo(Aichi Cancer Center), Min‐Ho Shin(Chonnam National University Hospital), Wei Hu(National Institutes of Health), Yun‐Chul Hong(National University College), Xu‐Chao Zhang(Guangdong Academy of Medical Sciences), Xiao‐Ou Shu(Vanderbilt University Medical Center), Charles E. Breeze(National Institutes of Health), Yang Yang(Tongji University), Wei Zheng(Vanderbilt University), Jin Hee Kim(Sejong University), Kexin Chen(Harbin University of Science and Technology), Yi‐Long Wu(Guangdong Academy of Medical Sciences), Dongxin Lin(Sun Yat-sen University), Zhaoming Wang(St. Jude Children's Research Hospital), Hee Nam Kim(Chonnam National University), Young‐Chul Kim(Chonnam National University Hwasun Hospital), Maria Pik Wong(Queen Mary Hospital), Young Tae Kim(Pukyong National University), Lap Ping Chung, Bao Song(Shandong Tumor Hospital), I‐Shou Chang(National Health Research Institutes), Maria Teresa Landi(National Cancer Institute), Brian Richardson(University of North Carolina at Chapel Hill)
Cited by 70
Related Papers
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
|New England Journal of Medicine|2009|8.2k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k